share_log

Avenue Therapeutics | EFFECT: Others

Avenue Therapeutics | EFFECT:其他

SEC announcement ·  02/02 06:05
Moomoo AI 已提取核心信息
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of February 1, 2024, at 5:00 P.M. The SEC's notice of effectiveness indicates that the company's registration statement has been accepted, allowing Avenue Therapeutics to issue securities as detailed in the filing under file number 333-276671.
Avenue Therapeutics, Inc.已于2024年2月1日下午5点宣布自2024年2月1日下午5点起向美国证券交易委员会(SEC)提交的S-3表格生效。美国证券交易委员会的生效通知表明该公司的注册声明已被接受,允许Avenue Therapeutics发行文件中详述的证券,文件编号为333-276671。
Avenue Therapeutics, Inc.已于2024年2月1日下午5点宣布自2024年2月1日下午5点起向美国证券交易委员会(SEC)提交的S-3表格生效。美国证券交易委员会的生效通知表明该公司的注册声明已被接受,允许Avenue Therapeutics发行文件中详述的证券,文件编号为333-276671。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息